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Abstract
The properties of a semipermeable porous membrane, including pore size, pore density, and
thickness, play a crucial role in creating a tissue interface in a microphysiological system (MPS)
because it dictates multicellular interactions between different compartments. The small
pore-sized membrane has been preferentially used in an MPS for stable cell adhesion and the
formation of tissue barriers on the membrane. However, it limited the applicability of the MPS
because of the hindered cell transmigration via sparse through-holes and the optical translucence
caused by light scattering through pores. Thus, there remain unmet challenges to construct a
compartmentalized MPS without those drawbacks. Here we report a submicrometer-thickness
(∼500 nm) fibrous extracellular matrix (ECM) film selectively condensed on a large pore-sized
track-etched (TE) membrane (10 µm-pores) in an MPS device, which enables the generation of
functional tissue barriers simultaneously achieving optical transparency, intercellular interactions,
and transmigration of cells across the membrane. The condensed ECM fibers uniformly covering
the surface and 10 µm-pores of the TE membrane permitted sufficient surface areas where a
monolayer of the human induced pluripotent stem cell-derived brain endothelial cells is formed in
the MPS device. The functional maturation of the blood–brain barrier (BBB) was proficiently
achieved due to astrocytic endfeet sheathing the brain endothelial cells through 10 µm pores of the
condensed-ECM-coated TE (cECMTE) membrane. We also demonstrated the extravasation of
human metastatic breast tumor cells through the human BBB on the cECMTE membrane. Thus,
the cECMTE membrane integrated with an MPS can be used as a versatile platform for studying
various intercellular communications and migration, mimicking the physiological barriers of an
organ compartment.
1. Introduction
Microphysiological systems (MPS) mimicking vari-
ous organ compartments in the human body attrac-
ted considerable interest due to their prodigious
potential to predict drug toxicity and efficacy that
was elusivewith conventional studies based on animal
models or 2D cell culture methods [1, 2]. Many
MPS devices consist of compartmentalized chambers
separated by in vitro basement membranes, particu-
larly to mimic the epithelial and endothelial tissues.
The basement membrane is a thin sheet-like extra-
cellular matrix (ECM) mainly composed of collagen
type IV and laminin networks that underlie epithelial
and endothelial cell layers, which play important
roles in structural support, building a barrier between
tissue compartments, and maintaining the cell phen-
otypes regulated by cell-ECM interactions. It actively
© 2021 The Author(s). Published by IOP Publishing Ltd
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interacts with the cells in a bidirectional manner
through the cell surface receptors to create func-
tional homeostasis of a specific tissue [3]. To mimic
the in vivo basement membrane in MPS, semiper-
meable polymer membranes have been popularly
used due to their simplicity to fabricate and relatively
strong mechanical property. The characteristic of the
semipermeable porous membranes is critical in con-
structingMPS because it determines the physiological
relevance, the permeability of biomolecules across
the membranes, and optical transparency permitting
versatile microscopic imaging. For the past decade,
polydimethylsiloxane (PDMS) porous membranes
have been widely employed, which are biocompat-
ible and stretchable; however, due to its polymer net-
work structure making it absorb small hydrophobic
molecules [4], it became an unfavorable material
for drug testing applications. Currently, chemically
resistant commercial synthetic membranes, such as
polyester (PE) and polycarbonate (PC) track-etched
(TE) membranes [5], have been extensively used as
substrates for tissue barriers, including blood–brain
barrier (BBB) [6], kidney proximal tubule [7], and
oviduct [8].
In selecting a commercial TE membrane for fab-
ricating MPS, several parameters, such as pore size,
pore density, and thickness, should be examined for
each dedicated application. The use of TEmembranes
having large pores (3 ∼ 10 µm) allows the wider
applications of MPS, including cell migration and
cancer metastasis through endothelial cell barriers
[5]. However, it may not be achievable to establish a
specific tissue barrier characteristic on a porousmem-
brane with a pore size larger than 3 µm due to the
unique property of cells [9, 10]. For example, brain
endothelial cells cannot form a distinct tissue bar-
rier on a porous membrane with a pore size >3 µm
because they readilymigrate through the pores, which
inhibits the development ofMPSmimicking transen-
dothelial migration of cancer cells through a brain
endothelium layer [9]. On the other hand, the TE
membranes with a pore size in a range of 0.4∼ 2 µm
canprovide enough contact areas for generating func-
tional tissue barriers in MPS [5]. Those membranes,
however, limit the physical interactions between cell
populations growing on either side of the mem-
brane and hamper the modeling of cell transmigra-
tion through the membranes due to their small pore
sizes [5]. In addition, the membranes with high pore
density designed for robust paracrine communica-
tions are generally translucent due to the light scat-
tering through the membranes [5]. Because of the
limited repertoire of commercial TE membranes, it is
still challenging to construct a porous membrane in
MPS that simultaneously satisfies the needs described
above.
To overcome these problems and replace
synthetic polymer-based membranes, vitrified ECM
membranes were developed to more precisely mimic
the biophysical and biochemical properties of nat-
ive basement membranes [11]. This approach was
advantageous over the conventional membrane
inserts because they closely replicate the basement
membranes’ structure and compositions. How-
ever, the vitrified ECM membrane with the manip-
ulable thickness (20 µm) hindered efficient molecu-
lar transport across the membrane. In addition,
the method reported for integrating the vitrified
ECM membranes with the PDMS devices using
PDMS precursors is not applicable to fabricating
MPS with chemically inert thermoplastic materials,
such as PC and polymethylmethacrylate (PMMA),
because it involves chemical and plasma treatment
that may lead to inactivation of inherent ECM
properties.
This study reports a thermoplastic MPS device
incorporating highly permeable TE membranes with
a pore size of 10 µm where tissue-specific ECM
molecules are condensed to formnanoscalemonolay-
ers that close the through-holes while mimicking the
native basement membranes surrounding an organ
compartment. Because of the adjustable thickness
of the ECM nanofilms on the TE membranes (less
than 1 µm), the molecular and cellular interactions
between the cells cultured on the upper and lower
sides of the membrane, respectively, are significantly
facilitated. More importantly, the proposed approach
permits the transmigration of cancer cells across the
BBB endothelial monolayers, which is unachievable
with the MPS fabricated with TE membranes of pore
sizes around 1 µm. The improved optical clarity
enabled by the larger pore size (10 µm) also allows
us to visualize three-dimensional (3D) cell configur-
ation more clearly, even across the condensed-ECM-




Cytolight Green-expressing human umbilical vein
endothelial cells (HUVECs; Sartorius) were cultured
in complete endothelial cell medium (ECM; Scien-
Cell) supplemented with endothelial cell growth sup-
plement (ScienCell), 5% fetal bovine serum (FBS;
ScienCell), and 1% penicillin/streptomycin (P/S;
ScienCell) solution. Human lung adenocarcinoma
cells (A549, ATCC® CCL-185™) were cultured in
Ham’s F12 medium (Welgene) containing 10% FBS
and 1% P/S solution. Human primary astrocytes
(Cat#1800; ScienCell) were maintained in Astrocyte
Medium (ScienCell) and used at passage number 4.
MCF-7 and MDA-MB-231 (KCLB) were maintained
in RPMI1640medium (Welgene) supplemented with
10% FBS and 1% P/S. Each cell was cultured at 37 ◦C
and 5% CO2 incubator (ICO105; Memmert). Each
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mediumwas replaced every 2–3 d, and cells were sub-
cultured or harvested when they reached around 80%
confluency.
2.2. Human brain microvascular endothelial cell
(hBMEC) culture and differentiation
The human induced pluripotent stem cell (iPSC)
line (IMR90-4) was purchased fromWiCell Research
Institute and maintained on Matrigel (Corning)
using TeSR™-E8™ (STEMCELL Technologies)
according to WiCell Feeder Independent Pluripotent
Stem Cell Protocols provided by the WiCell Research
Institute (www.wicell.org). hBMECs were differ-
entiated from iPSCs as previously described with
minor modification [6]. To generate the hBMECs,
IMR90-4 iPSCs were singularized using Accutase
(Merck) and seeded on a 6-well plate coated with
Matrigel at a density of 1.7 × 104 cells per well. Sin-
gularized cells were cultured with TeSR™-E8™ for
3 d until the concentration reaches 2.5× 105 cells per
well. To initiate differentiation (D0), the meddium
was switched to the unconditioned medium (UM).
UM is composed of 78.5% DMEM/F12 (Gibco),
20% Knockout™ Serum Replacement (Gibco), 1%
non-essential amino acids (100×) (Gibco), 0.5%
GlutaMAX™ supplement (Thermo Fisher Scientific),
and 0.007% β-mercaptoethanol (Gibco). The culture
medium was replaced every day by the fresh UM
medium until D5. The endothelial cells were select-
ively expanded for 2 d (D6–D7) by switching to ECM,
including human endothelial serum free medium
(SFM) (Gibco) supplemented with 1% human serum
(Sigma), 20 ng ml−1 bFGF (Peprotech), and 10 µM
retinoic acid (Sigma). Cells were exposed to low oxy-
gen tension (5% O2, 5% CO2) during differentiation
(from D0 to D8) using a hypoxic chamber (Galaxy®
48 R; Eppendorf) [6].
2.3. Microfluidic device fabrication
Microfluidic channels were fabricated by
engraving surface of PMMA substrates
(width × height × depth; 10 cm × 5 cm × 1.5 mm)
by a computer numerical control milling machine
(David 3020C; David). Depending on experimental
conditions and cell lines, different microchan-
nel dimensions were used. The general width of
microchannels was identical (width; 800 µm), in
using HUVEC and A549 cell lines, the depths
of microchannels were 200 µm. For hBMECs,
deeper depths of 500 µm were used to expand
the medium access. To improve optical transpar-
ency, milling marks on the microfluidic chan-
nel surface were removed by filling the inside of
the PMMA microfluidic channels with 80% eth-
anol (Biosesang) and placing them in a convection
oven at 100 ◦C (C-D0D1; Changshin Science) for
1 min. The microfluidic device was composed of two
microchannels separated by a thin, porous polyester
track-etched (PETE; SterliTech, it4ip) membrane,
and it was fabricated as previously reported [12].
After the device fabrication, the microchannels were
washed with isopropanol, ethanol, and deionized
water sequentially. Then, the device was dried with
nitrogen gas and kept in a sterile environment until
the ECM coating process.
2.4. Condensed ECM coating
Collagen was used as the primary ECM coat-
ing solution. Various concentrations (2, 1, 0.125,
0.06 mg ml−1) of rat tail collagen type I (Thermo
Fisher Scientific) solutions were prepared through
the manufacturer’s protocols. The condensed ECM
coating was achieved by injecting the prepared colla-
gen solution into themicrochannels of the device and
performing the air-dry. During the process, to min-
imize the collagen sticking to the microchannel wall
and ensure that the collagen was primarily coated on
the porous TE membrane, each channel was blocked
with the 3% bovine serum albumin (BSA; Sigma)
solution for 1 h in an incubator (37 ◦C and 5% CO2).
The microchannels were then filled with the pre-
pared collagen solution. Air bubbles trapped inside
themicrochannel were checked and removed through
pipetting before the collagen gelation. The device was
incubated at 37 ◦C for 2 h to complete the collagen
gelation inside the microchannel, and it was moved
to a sterile environment and dried overnight to con-
dense the collagen to form an ECM nanofilm on the
TE membrane.
2.5. Contact angle measurement
PMMA substrate and PETE membrane were coated
with the BSA for 1 h in an incubator (37 ◦C and 5%
CO2). Water droplets dropped on each surface of the
PMMA substrate and PETE membrane, and the con-
tact angle of droplets was measured by the contact
angle analyzer (Phoneix 300; Surface Electro Optics).
2.6. Scanning electronmicroscopy (SEM)
For SEM imaging, the cECMTE membrane samples
were collected by disassembling the microfluidic
device. The collected membrane was cut to a smal-
ler size that includes the microchannel portion where
the cECMTE membrane was formed. The samples
were sputtered with platinum and mounted on the
SEM microscope (S4800; Hitachi High Technolo-
gies). SEM images were taken to confirm the mor-
phological characteristics of the cECMTEmembrane.
The obtained images were analyzed by ImageJ.
2.7. Microfluidic cell culture
To qualitatively compare the effect of the PETE
membranes’ pore size and porosity on the optical
transparency, GFP-HUVEC was cultured in the
upper channel spaces of the condensed ECM-coated
microfluidic device, which integrated with differ-
ent pore-size (1, 5, and 10 µm) PETE membranes.
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The microfluidic channels were washed with 1×
phosphate-buffered saline (PBS; Biosesang) and filled
with ECM, at least for 30 min for the ECM rehyd-
ration process. Then the culture medium with the
suspended HUVEC (3 × 106 cells ml−1) was injec-
ted into the upper microfluidic channel of the device
and allowed the cells to attach to the PETE mem-
brane surface under static conditions for at least
1 h. After the cell attachment was confirmed, the
microfluidic device was connected to a syringe pump
(Fusion 200; Chemyx Inc.), and the culture medium
were infused through each channel at a flow rate of
2 µl min−1. After 48 h, once cell monolayers were
confluently established on the cECMTE membrane,
cell images were visualized using a fluorescent micro-
scope (EVOS® FL; Thermo Fisher Scientific). Each
image was obtained by accepting emission light of the
cell pass through the pores of the PETE membrane
with an objective lens of the microscope.
To verify that cells were cultured within a spe-
cified compartment of the microfluidic device, GFP-
HUVEC and A549 were cocultured in the upper and
lower side of the cECMTE membrane of the device,
respectively. GFP-HUVEC cells were seeded in the
same process as described above. For seeding A549
cells, the microfluidic device was flipped, and A549
cells (5 × 106 cells ml−1) suspended in the culture
medium were injected into the lower microfluidic
channel and allowed to attach to the lower side of
the PETE membrane surface under a static condi-
tion for 1 h. After 48 h of cultivation with the syringe
pump (2 µl min−1), 5 µM solution of CellTrackerTM
Red (Thermo Fisher Scientific) was loaded into the
lower microchannel and then incubated (37 ◦C, 5%
CO2) for 30 min to stain the A549 cells. The micro-
fluidic channel was then flushed with 1× PBS to clear
the remaining dye solution. To visualize 3D rendered
images of cell monolayers, the confocal microscope
(LSM 980 Configuration 16 NLO; Carl Zeiss, USA)
was used.
2.8. Optical properties of TEmembranes
The aberrations due to the TE membranes were veri-
fied by directly measuring the point spread functions
(PSFs) through the membranes. The same experi-
mental geometry as in observation of cultured cells
was replicated by using two different objective lenses
for (a) illumination onto and (b) detection through
the two different sides of themembranes. Rather than
the cultured cells emitting fluorescence, an optical
focus generated by the illumination objective was
used as the emitting light source for PSF measure-
ments. The illumination and detection objectives had
numerical apertures (NA) of 0.5 and 0.3, respect-
ively. As the illumination objective lens has a higher
NA, an effective point source could be generated on
the top surface of the TE membranes. The detec-
tion objective was then focused on the same layer to
observe the effective PSFs after light from the point
source propagated through the membranes. For each
membrane, ten PSFs were measured over random
positions across the membrane surface and averaged
to obtain the effective PSF. The structural similarity
index (SSIM) values of each image were calculated by
using MATLAB.
2.9. BBB reconstruction inMPS device
For culturing hBMECs on a microfluidic device,
an overall condensed ECM coating process was
employed as described above except for the con-
centration of collagen type I (0.125 mg ml−1).
The microchannels pre-coated with the condensed
ECM (collagen type I) were additionally coated
with the mixture of 400 µg ml−1 collagen type
IV (Sigma) and 100 µg ml−1 human fibronectin
(Sigma). After overnight incubation at 37 ◦C, the
microchannels were dried at room temperature for
20 min, followed by aspiration of coating solutions
and rehydrating the channel using EC medium. For
the co-culture of astrocytes and hBMECs, human
astrocytes (1 × 106 cells ml−1) were seeded on the
lower side of the cECMTE membrane of the chan-
nel. The device was flipped and incubated for 2 h
to allow the astrocytes to completely attach to the
lower side of the membrane. After the astrocytes were
stably attached, both channels were flushed with EC
medium, and hBMECs were seeded with a density
of 1.2 × 107 cells ml−1 on the upper side of the
cECMTE membrane. After 6 h of seeding hBMECs,
the ECmediumwas carefully exchanged through inlet
and outlet holes to avoid nutritional deficiencies and
dryness of the cells. The device was maintained at
37 ◦C in a 5% CO2 incubator for 24 h and fed with
the fresh EC medium deprived of bFGF and retinoic
acid. All follow-up assays were carried out after 2 d of
culture.
2.10. Immunofluorescence imaging
On the third day of hBMECs and astrocytes seed-
ing on the device, cells were fixed for 15 min at
room temperature by flushing 4% paraformaldehyde
(Biosaesang) and permeabilized with 0.1% Triton X-
100 (Sigma) in Dulbecco’s phosphate buffered saline
(DPBS) for 10 min. After blocking the cells with 10%
goat serum diluted in PBS containing 0.1% Triton X-
100 for 1 h at room temperature, samples in a micro-
fluidic channel were treated with primary antibod-
ies and incubated at 4 ◦C overnight. After the wash-
ing procedure, secondary antibodies were treated for
1 h at room temperature. Primary antibodies used in
this study are listed in table S1 (available online at
stacks.iop.org/BF/13/045020/mmedia). The second-
ary antibodies fluorescently conjugated with Alexa
Fluor-488, Alexa Fluor-594, or Alexa Fluor-647 were
used with 1:200 dilution when the primary antibod-
ies are not conjugated. Nuclei were counterstained
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with 4′,6-diamidino-2-phenylindole (DAPI;Sigma).
Fluorescence images of cells were obtained using
fluorescence microscopy (Nikon), confocal micro-
scopy LSM780NLO (Zeiss), and LS980 (Zeiss).
2.11. qRT-PCR
Total RNA of hBMECs within a microchannel
was extracted on the third day of seeding using a
AccuPrep® Universal RNA Extraction Kit (Bion-
eer) and reverse-transcribed into cDNA using
AccuPower® RT PreMix & Master Mix (Bioneer) in
a thermal cycler (T100 Thermal Cycler; Bio-Rad).
The quantitative real-time PCR was carried out using
SYBR® Green Realtime PCR Master Mix (TOYOBO)
on a CFX Connect Real-Time PCR Detection System
(Bio-Rad). Table S2 shows the primer sequences used
for real-time PCR.
2.12. Permeability assay
To measure the barrier function of the BBB, the
BBB in an MPS device incorporating a 10 µm-pore
cECMTE membrane additionally coated with BBB
ECM (collagen IV and fibronectin) was used. The
BBB on the 1 µm-pore PETE membrane coated
with the BBB ECM were used as a control. On
D10, 100 µg ml−1 of Lucifer yellow (Invitrogen) was
applied to the upper channel (blood side) while the
lower channel (brain side) was blocked. After 1 h of
incubation, themedium from the brain side was care-
fully collected. The fluorescence of the samples was
analyzed at 420/540 nm using a microplate reader
(SynergeNeo2; Biotek). Apparent permeability is cal-





C0 is the applied concentration and Cx is a measured
concentration of the collected sample at time t. A is
the area of the membrane within the channel, and
V is the volume of the brain side channel, which is
0.16 cm2 and 0.008 ml, respectively, in our device.
2.13. Cancer cell transendothelial migration assay
Two types of human breast cancer cell lines, MCF-
7 and MDA-MB-231, were labeled with CellTracker
Green by incubating for 20 min at 37 ◦C. Followed
by three times of washing, the labeled cancer cells
were introduced to the upper channel of the BBBMPS
(blood side) with a density of 3× 106 cell ml−1. After
coculturing for 24 h, the devices were washed with
DPBS to remove unattached cancer cells. To indicate
the BBB layer, hBMECs were stained with ZO-1 anti-
body as described in the experimental section. In the
device, the cells in transmigration steps were counted
by taking an image of the entire microfluidic channel.
The transmigrated and non-transmigrated cells were
clearly distinguished in z-stack images under obser-
vation with the confocal microscope LSM980 (Zeiss).
3. Results and discussion
3.1. Fabrication of the cECMTEmembrane
integrated with anMPS
The ECM hydrogel is a porous and biocompatible
material consisting of a 3D hydrophilic network of
cross-linked polymers [13]. As the primary struc-
tural protein of the ECM, collagen forms the hier-
archical network of fibrils much like the native tis-
sue and acts as scaffolds for tissue engineering [14].
The temperature-responsive gelation of type I colla-
gen can primarily provide the fibrillate network and
has already been extensively studied [15, 16]. Asmen-
tioned, there were attempts to create a vitrified ECM
membrane with the inspiration of collagen’s char-
acteristics as a structural protein [11, 17–19]. How-
ever, since those membranes were fabricated by a
sequential process of gelation and dehydration of the
ECMproteins, there were no support fixtures embed-
ded in the membrane, and it was wrinkle-prone and
had limited mechanical properties. Also, it was chal-
lenging to integrate that membrane with synthetic
polymer devices since any chemical glue or plasma
treatment was not available with the native ECM
protein membrane. Based on this consideration, we
combined the ECM membrane on the premanufac-
tured polymeric base membrane to easily produce a
synthetic polymer MPS device advancing the tissue
engineering study in a microscale regime.
We formed the fibril network that surrounds the
pre-integrated hydrophilic porous PETE membrane
in the PMMA MPS device using type I collagen.
Microchannels of a microfluidic MPS device were
used as a mold system to condense the injected col-
lagen solutions onto the PETE membrane to form
nanoscale monolayers that mimic the native base-
ment membrane (figure 1(a)). Depending on the
microchannel volume, a certain amount of colla-
gen was uniformly introduced into the microfluidic
channels, and thermal gelation proceeded at 37 ◦C.
After the collagen was firmly gelated, the water inside
the collagen hydrogel evaporated by air-drying. Con-
sequently, the volume of the hydrogel highly reduced,
resulting in the condensed fibril network of colla-
gen fibers, which also led to forming robust mech-
anical strength. During the condensation process,
the nanofilm structure of the collagen fibers adhered
tightly on both the upper and lower surface of the
PETE membrane without any toxic chemical glue or
plasma bonding (figure 1(a)). Before introducing the
collagen, the microchannels were blocked with BSA
to prevent the collagen matrix from being adsorbed
onto the channel wall surface. Despite the BSA coat-
ing on the PETE membrane and the PMMA chan-
nel surface, the collagen fibers were still preferen-
tially condensed on the PETE membrane rather than
the PMMA channel surface due to the higher sur-
face energy of the PETE membranes than the PMMA
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Figure 1. A schematic drawing of the fabrication process and SEM images of the condensed ECM. (a) The fabrication process of
the cECMTE membrane inside the MPS device. (b) Representative photographs of the fabricated MPS device before and after
condensing ECM on the TE membrane. Scale bar= 1 cm. (c) SEM images of the cross-sections of the fabricated MPS device and
(d) PETE membrane coated with condensed ECM (type I collagen, 2 wt %). Scale bars= 200 and 10 µm, respectively. (e) SEM
images of the cECMTE membrane surface (top view). Scale bar= 200 µm (The inset images show pores in each area of the PETE
membrane. Scale bar= 5 µm). ((f) and (g)) Magnified SEM images of the cross-sections of the condensed ECM film formed in
the MPS device. Scale bars= 2.5 µm and 500 nm, respectively.
channel surface. The contact angles measured on the
surface of a PMMA substrate and a PETE mem-
brane, each of which was coated with BSA, were
10.05 ± 0.26◦ and 0◦, respectively (figure S1). This
supports that the higher surface energy of the PETE
membrane than the PMMA substrates allowed the
ECM solution to selectively condense onto the PETE
membrane rather than onto the PMMA channel sur-
face. Figure 1(b) represents photographs of the MPS
devices before (left panel) and after (right panel) the
condensed ECM coating process. After the coating,
we observed that the channel part turned optically
opaque, which indirectly confirmed the formation of
the fibril matrix with the naked eye. However, the
cECMTE membrane returned to a transparent state
once priming the channel with a culture medium to
rehydrate the membrane.
Next, we directly observed the cECMTE mem-
branes’ surface morphology and nanofibrous struc-
ture using SEM images (figures 1(c)–(g)). Figure 1(c)
shows a cross-sectional image of the MPS device
containing the cECMTE membrane. A 10 µm-pore
PETE membrane was located in between the upper
and lower channels. A magnified view of the PETE
membrane verified the presence of the condensed
ECM nanofilm adhered on both the upper and
lower sides of the membrane (figure 1(d)). On the
surface of the PETE membrane disassembled from
6
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the channel, distinctively visible condensed collagen
fibers evenly covered the microchannel area of the
porous membrane (figure 1(e), right inset panel). In
contrast, the rest of the area remained without being
coated with condensed ECM (figure 1(e), left inset
panel). A magnified image of the 10 µm-pore mem-
brane showed that randomly oriented collagen fibers
were densely packed to organize the gapless mesh
structure and closed the pore (figure 1(e), right inset
panel). The structure or the porosity of the fibril-
lated collagen mesh was also adjustable by changing
a collagen concentration. We condensed a range of
concentrations of type I collagen (0.06, 0.125, 1, and
2 mg ml−1) onto the 10 µm-pore PETE membranes
in the MPS device and found that the minimal col-
lagen concentration required for covering the pores
without voids should be in a range between 0.125 and
1 mg ml−1 (figure S2). Figures 1(f) and (g) shows
the representative cross-sectional images of the con-
densed ECM in a nanofilm structure. The thickness
of the film was around 500 nm when 2 mg ml−1
of collagen was used. It was adjustable in several
ways; by changing the concentration of the colla-
gen solution, modifying the channel dimension to
vary the volume of the collagen solution introduced
into the microchannel, and continuously overlaying
the condensed ECM on the same membrane. These
SEM images of the ECM nanofilms revealed the mor-
phology of the densely packed multilayered collagen
fibers that mimic the native ECM nanofiber struc-
ture, and these morphological characteristics permit-
ted robust mechanical property of the ECM mem-
brane and more abundant opportunities for cells
to interact with the surrounding microenvironment
in comparison to a solution-based ECM coating
method.
3.2. Optical properties of porous PETEmembranes
To construct the MPS, the optical properties of the
membrane to accurately profile live cells are import-
ant [20]. Synthetic TE membranes are commercially
available with a variety of options of pore sizes and
densities. Those porousmembranes allow light trans-
mission through the surface to visualize cells on each
side of the membrane. However, the transmitted
light onto the membrane is scattered due to spacing
between pores or its perforated angle, and it often
generates some background signals, making images
blurry and limit the application of themembrane [5].
In general, the membranes with lower pore density
appear to have lower background signal. As themem-
brane with large pores does not allow uniform cell
seeding, small pore-sized membranes (0.4 ∼ 2 µm)
with lowporosity have been preferentially used to cul-
ture the cells to achieve better optical clarity and cell
adhesions. However, these membranes limit intercel-
lular communications between cells on each side of
the membrane because of sparse through-holes and
small open areas.
After confirming that the type I collagen could
act as a scaffold by blocking pores of the porous
membrane, we compared the commonly used PETE
membranes of 1, 5, and 10 µm-pore sizes to verify
that the membrane with the large pore is optic-
ally advantageous over other membrane options. For
the comparison, we first measured the effective PSFs
that are obtained after the light path is aberrated
passing through the PETE membranes (figure 2(a)).
We then simulated predicted fluorescence images
based on the measured PSFs of the PETE mem-
branes with different pore sizes and pore densities.
By applying convolution of an aberration free image
of cells taken under membrane-free conditions with
the aberrated PSFs due to the PETE membranes, we
visualized artificial images of the cultured cells on
each membrane (figure 2(b)). The quality of each
aberrated image was then compared to the ground
truth image by using the SSIM [21]. SSIM values
range from 0 to 1, where 1 corresponds to a per-
fect match between the ground truth and aberrated
images. For the images aberrated by low pore dens-
ity 1 µm-pore and 10 µm-pore PETE membranes,
SSIM values were 0.95 and 0.96. However, at high
pore density 1 µm-pore and 5 µm-pore PETE mem-
branes, SSIM values dropped to 0.74 and 0.86 (figure
S3). These results reflect that the low pore density
membrane or large pore size membrane are more
optically transparent and offer superior image quality
closer to themembrane-free condition.Next, the sim-
ulated images were compared with actual images of
cultured cells (GFP-HUVECs) on the cECMTEmem-
brane (figure 2(c)). Comparing each image revealed
that the effects of condensed ECM on the optical
transparency of each membrane were minimal, and
the transparency of the cECMTE membrane contin-
ues to vary depending on the density and size of the
pores. As shown in figures 2(b) and (c), when the
membrane pore size increased, or the density of the
pores decreased, the optical properties were improved
with reduced background haze and clearer cell
visibility.
To visualize the 3D MPS constructed in a micro-
fluidic device, the z-stacking feature of a confocal
microscope was utilized for slicing and integrat-
ing images along the z-axis of the MPS device
(figure 2(d)). As shown in the reconstructed 3D
image, the cell monolayers in the upper (GFP-
HUVEC, green) and lower (A549, red) sides of the low
pore density 1µm-pore PETEmembrane (figure 2(d)
left) and 10 µm-pore PETE membrane (figure 2(d)
right) were visually distinguishable while they were
not optically partitionable due to the intense light
scattering through the high pore density 1 µm-pore
PETE membrane (figure 2(d) middle).
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Figure 2. Optical properties of different pore-sized PETE membranes. (a) PSF of PETE membranes with different porosity and
pore sizes. Scale bar= 5 µm. (b) Convoluted images of the obtained PSF by applying to the reference GFP-HUVEC image taken
without a membrane condition. Scale bar= 100 µm. (c) The actual images of GFP-HUVECs cultured on each cECMTE
membrane. Scale bar= 100 µm. (d) Representative 3D coculture images of GFP-HUVECs and CellTracker Red-stained A549 on
the different pore-sized PETE membranes.
Overall, while both the low pore density 1 and
the 10 µm-pore PETE membrane resulted in com-
parable outstanding optical transparency, the larger
poremembrane is predicted to bemore advantageous
in creating MPS because of the facilitated cellular
interactions and transmigration of cells across the
membrane.
3.3. BBB reconstruction and characterization on a
cECMTEmembrane in anMPS device
We next explored the application of the PMMAMPS
device in the reconstitution of human BBB. The
BBB functions as a specialized physiological barrier
to protect the central nervous system by restricting
the entry of unwanted molecules from the blood
into the brain. This restrictive interface formed by
hBMECs limits the paracellular permeability and act-
ively pump out a massive variety of lipophilic drugs
through efflux transporters on the membrane. While
hBMECs form the main interface, they work in con-
certwith glial cells, including astrocytes that surround
tissue space extending their processes toward the
endothelium. They adapt to environmental changes
and regulate the functional maintenance of BBB
8
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Figure 3. Characterization of the BBB on the 10 µm-pore cECMTE membrane in the MPS device. (a) Bright field images showing
the morphology of hBMECs seeded on a 10 µm-pore cECMTE membrane. Scale bar= 200 µm. (b) Immunofluorescence images
of the hBMECs cultured on the device for 2 d stained with ZO-1, claudin5, occludin, and GLUT1. Scale bar= 10 µm. (c) The
apparent permeability of Lucifer yellow across the bare 1 µm-pore PETE membrane and the 10 µm-pore cECMTE membrane in
the empty MPSs without a cell monolayer. (d) The apparent permeability of Lucifer yellow across the hBMECs monolayers on the
1 µm-pore PETE membrane without condensed ECM and the 10 µm-pore cECMTE membrane in the BBB MPSs. The results are
presented as the mean± s.e.m. performed in triplicate. For statistical analysis, an unpaired t-test was performed (n.s., not
significant).
together through dynamic cell-to-cell communica-
tions [22–24]. Thus, multicellular BBB models have
found increasing applications to study molecular
mechanisms underlying tumor cells or drug per-
meability across the dynamic interface.
In general, PETE membranes with a small pore
size (0.4∼ 2 µm) are used for culturing iPSC-derived
hBMECs [6] because PETE membranes with large
pores (>5 µm) are not able to support the stable
attachment of hBMECs on the substrate due to the
low contact area [10]. However, the use of a small
pore-sized membrane limited the application range
of the BBB model.
We set out to generate a human BBB mono-
layer on a 10 µm-pore cECMTE membrane in the
PMMA MPS device. Human iPSC-derived BMECs
were seeded on the cECMTE membrane in the
upper microchannel with different cell densities.
The endothelial monolayer was successfully formed
within 24 h when hBMECs were seeded at a density of
1.2× 107 cells ml−1 (figure 3(a)). However, hBMECs
plated at a higher density (1.7 × 107 cells ml−1)
showed low cell attachments because of nutri-
tional and oxygen deficiency (data not shown).
The cells were not observed in the lower channel
since the condensed ECM provided enough contact
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area, preventing hBMECs from passing through the
10 µm-pores. After 2 d of hBMECs culture, confocal
immunofluorescence microscopic analysis revealed
the tight junctional integrity of the BBB, showing
the localization of tight junction proteins, includ-
ing ZO-1, claudin-5, and occludin, at the endothelial
border (figure 3(b)). It also showed the expression
of GLUT1, which is responsible for glucose transport
across the BBB (figure 3(b)).
The barrier integrity of the BBB was examined
by analyzing the paracellular transport of Lucifer yel-
low (457.3 g mol−1) in the BBB MPS (figures 3(c)
and (d)). To compare with a previous method, the
BBB integrity was measured in two types of the
MPS devices assembled with different membranes—
the PETE membrane with small pores (1 µm)
without condensed ECM as a positive control and
the 10 µm-pore cECMTE membrane. The insignific-
ant difference in the permeability between the two
types of membranes was determined in the empty
MPS devices without a cell monolayer (figure 3(c)).
As shown in figure 3(d), the apparent permeabil-
ity of Lucifer yellow across the BBB monolayer on
the cECMTE membrane was comparable to those
obtained from the BBB culture on the PETE (1 µm)
membrane, implying that the reconstructed BBB
on cECMTE offers physical barriers as strong as
the conventional BBB culture on the 1 µm-pore
PETE membrane effectively limiting the paracellular
diffusion.
3.4. A highly permeable cECMTEmembrane
facilitates physical contact between brain
endothelial cells and astrocytes, leading to the
maturation of BBB
It is generally accepted that commercially available
small pore-sized PETE membranes (0.4 ∼ 2 µm)
with high transparency allow only chemical commu-
nications between hBMECs and astrocytes [25, 26].
We hypothesized that a large pore-sized (10 µm)
cECMTE membrane would promote the astrocytes
to interact with the brain endothelial layer with
their endfeet by extending the processes through
the pores, reproducing a more in vivo-like pheno-
type (figure 4(a)). To reconstitute the multicellular
BBB in the MPS device, human primary astrocytes
were seeded in the lower channel and incubated for
2 h after flipping the device to allow the cells to
be attached on the membrane. A confocal micro-
scopic image from the side view revealed that astro-
cytic processes are in close contact with hBMECs
by penetrating the cECMTE membrane (figure 4(b)
and video 1). A confocal image taken at the lower
side of the membrane showed that some pro-
cesses of astrocytes sent out projections toward a
pore (figure 4(c), bottom panel) and terminated in
prolongation localized with hBMECs (figure 4(c),
upper panel), forming the 3D structure of astrocytic
endfeet.
Next, we analyzed mRNA expressions of the BBB
functional genes in iPSC-derived hBMECs, which
are known to be enhanced by coculture with astro-
cytes [27]. The mRNA expressions were compared
between hBMECs monoculture and coculture on
each type ofmembranes to test if these different pore-
sized membranes (1 and 10 µm) sufficiently sup-
port the interplay between hBMECs and astrocytes.
As shown in figure 4(d), when hBMECs were cocul-
tured with astrocytes on the 10 µm-pore cECMTE
membrane, mRNA expressions of glucose trans-
porter protein (SLC2A1), drug efflux pump protein
(ABCB1, ABCC4), tight junction protein (CLD5),
and endothelial junction (PECAM-1) were increased
by 1.5 ∼ 2-fold compared to those in the mono-
culture condition. In contrast, when hBMECs were
cocultured with astrocyte on the 1 µm-pore cECMTE
membrane in the same device, mRNA expressions
were not markedly changed due to physical obstruc-
tion of small pores. However, the barrier integrity
of the monolayer of hBMECs coculture was not
apparently changed by co-culture with astrocytes in
the BBB MPSs (figure S4). These studies revealed
that hBMECs-astrocytes interaction may have been
more facilitated in the large pore-sized membrane
via the formation of astrocytic endfeet and bet-
ter exchange of secreted factors through the lar-
ger open area (>5 times) of the 10 µm-pore PETE
membrane.
3.5. 10 µm-pore cECMTEmembranes permit
transendothelial migration on the BBBMPS
To further investigate the potential of the BBB MPS
as an in vitro platform to study tumor metastasis,
we investigated the transmigration of two different
human breast tumor cells, MCF-7 and MDA-MB-
231, in the BBB MPS. Our BBB MPS was assumed
to provide a through-hole diameter (10 µm) large
enough for tumor cells to migrate across the BBB
while the past in vitro BBB models using small
pore-sized membranes (0.4 ∼ 2 µm) did not suffi-
ciently allow the tumor cell migration through pores
(figure 5(a)). To monitor the adhesion and extravas-
ation of metastatic tumor cells (MDA-MB-231) and
non-metastatic tumor cells (MCF-7) in the BBB, both
types of cells were labeled with CellTracker Green
and introduced to the upper channel of the BBB
MPS. We compared the number of cells adhered
to hBMECs between MDA-MB-231 and MCF-7 to
ensure that they were responding to endothelium
depending on their aggressiveness. In the BBB MPS,
highly metastatic MDA-MB-231 adhered to hBMECs
three times more than MCF-7 at 24 h after the tumor
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Figure 4. Formation of astrocytic endfeet through the 10 µm-pore cECMTE membrane in the BBB MPS. (a) A schematic image
of the BBB MPS cocultured with astrocytes on a different pore-sized cECMTE (1 and 10 µm). This figure was created with
BioRender.com. (b) A side view of 3D reconstructed confocal z-stack images showing astrocytes (green, GFAP staining) extending
the processes through the pores where they were found contacting hBMECs (red, ZO-1 staining) in the BBB MPS. A video of
overlay z-stack reconstituting the 3D BBB structure is shown in movie 1 in the supporting information. (c) Fluorescent images
collected from the apical side (upper panel) and the basal side (lower panel) of the cECMTE at the same x and y position. The
bright field images were merged to show the location of pores. The yellow arrow indicated the astrocytic endfoot through the
hole. Scale bar= 40 µm. (d) Quantitative RT-PCR of the BBB on 1 and 10 µm-pore cECMTE membrane. The results are
presented as the mean± s.e.m. and performed in triplicate. For statistical analysis, an unpaired t-test was performed. (∗P < 0.05).
cells were introduced, which was consistent with pre-
vious studies (figure S5) [28, 29]. The extravasa-
tion event was observed using confocal microscopy
at the surface and cross-sectional views. As shown
in figures 5(b) and S6, MCF-7 cells labeled with
a green dye were found only on the apical side of
hBMECs, denoted by ZO-1 staining in red. In con-
trast, MDA-MB-231 cells were captured at the lower
channel where they have transmigrated across the
BBB (figures 5(c) and S6). Together, these results sup-
port that the 10 µm-pore cECMTE membrane in
the MPS device can recapitulate the dynamic inter-
action of the BBB with tumor cells with different
invasive potential and enable a well-visualized study
of tumor extravasation in the brain (figures 5(b),
(c) and S6).
11
Biofabrication 13 (2021) 045020 B Choi et al
Figure 5. Transendothelial migration of breast cancer cells through the 10 µm-pore cECMTE membrane in the BBB MPS.
(a) A schematic image showing the BBB MPS cocultured with two types of breast cancer cells (MCF7 and MDA-MB-231). This
figure was created with BioRender.com. (b) Representative 3D-reconstructed images of immunofluorescence staining of ZO-1
(red) indicating hBMECs and CellTracker Green-stained MCF-7 cells. Scale bar= 40 µm. (c) Representative 3D images showing
immunofluorescence staining of ZO-1 (red) and CellTracker Green-stained MDA-MB-231. The white arrow indicates an
MDA-MB-231 cell that transmigrated through the cECMTE membrane. Scale bar= 40 µm.
4. Conclusions
Fabrication of microphysiological barriers has been
a daunting challenge because mimicking their struc-
tural and functional characteristics is often lim-
ited by fabrication techniques, such as a resolution
of bioprinting and photolithography. Although TE
membranes have been employed to construct a tis-
sue barrier interface in an MPS due to their simpli-
city, there have been challenges, such as limited trans-
migration through a small pore-sized membrane,
poor adhesion of cells to the surface of a membrane
with large pore size, and optical translucence due to
light scattering through pores. Despite considerable
efforts in recent years, no fabrication approach was
developed, which could address these problems sim-
ultaneously. This is an important problem as it is
necessary for the cells on both sides of the porous
membranes to freely interact with their neighboring
cells and transmigrate through the barriers without
physical restriction because these confinements of the
cells could potentially mislead experimental results
obtained from the MPS platform.
Our approach offers the unique capability
in addressing all unmet needs in fabricating the
adjustable ECM-layered membrane integrated with
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an MPS. Due to the various extracellular features
in the tissue-specific microenvironment, it is also
critical to adjust ECM thickness and their composi-
tions. We demonstrated that the height of the fibrous
ECM films deposited on the TE membranes could be
determined by the concentration of ECM proteins in
a solution. This feature also could be accomplished
by changing the height of the microfluidic channel
because the channel volume determines the amount
of ECM proteins to be condensed on the surface.
Moreover, a mixture of a range of ECMproteins, such
as type I collagen, type IV collagen, fibronectin, and
Matrigel, can be used to form cECMTE membranes
once they are gelated in the microfluidic channel, and
additional coating with other ECM proteins on top
of the cECMTE surface is also practicable. Although
we validated our method using a 10 µm-pore size
PETE membrane, we could extend this to other types
of porous membranes of different materials, such as
PC, polyimide, and PDMS. In addition, TE mem-
branes with pore sizes larger than 10 µm could be
applicable depending on the requirement of mem-
brane permeability; however, we set out to examine
the 10 µm-pore TE membrane because it permit-
ted large pores enough for the cells to communic-
ate and translocate across the membrane. Given the
diverse chip configurations and fabrication process
of commercial MPS platforms or those on the way
to the market, our method could provide a versat-
ile utility in providing an adjustable ECM microen-
vironment of tissue-specific barrier interfaces in an
organ-mimicking in vitro analytical platform.
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